All research projects that will utilize recombinant or synthetic nucleic acid molecules, biological materials (e.g., infectious agents) and other potentially hazardous agents (e.g., carcinogens) must be submitted to the DU IBC for review and approval.
All IBC applications must be submitted online through the IRBNet system.
For more information on submissions, visit our Submission & MonitoringÌý±è²¹²µ±ð.
Forms
- IBC Main Application ¹ó´Ç°ù³¾Ìý(Word, PDF)
- Word: Amendment ¹ó´Ç°ù³¾Ìý(Word, PDF)
- Blood Draw/Fluid Collection ProtocolÌý(Word)
- Incident Report to NIH OBAÌý(Word, PDF)
- Final Progress ReportÌý(Word, PDF)
- Personnel Update Notification
- Appendix A: Lentivirus Assessment (LVRA) (Word)
Occupational Health Review Form
This form must be completed annually by all persons listed on a new protocol or three-year renewalÌýapplication. ÌýThis form must also be completed for any new personnel added to an approved protocol as part of the amendment submission and updated for all study personnel as part of the annual review/Post Approval Monitoring (PAM) process.
